Transcutaneous neuromodulation system and methods of using same
US12201833B2 · kind B2 · utility
Assignee
Inventors
Key dates
| Filing date | May 2, 2023 |
| Grant date | Jan 21, 2025 |
| Priority date | — |
| Expiry date | May 2, 2043 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61N1/36171
- WIPO fieldMedical technology
- WIPO sectorInstruments
Abstract
A neuromodulation system, device, and method are disclosed. In an embodiment, a neuromodulation system includes a processor, a signal generator, a first electrode, and a second electrode. The processor in cooperation with the signal generator, the first electrode, and the second electrode are configured to deliver a transcutaneous stimulation to a mammal. The transcutaneous stimulation is configured by the processor for inducing voluntary movement in the mammal. The first electrode is positioned transcutaneously on a spinal cord and/or spinal cord dorsal roots of the mammal. Additionally, the second electrode is placed transcutaneously on or over at least one of the spinal cord and/or the spinal cord dorsal roots, a muscle, a nerve, or on or near a target end organ or bodily structure of the mammal. The second electrode is in communication with the first electrode through a hardwire or wireless connection.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.